Pfizer seeks to expand omicron booster to 5- to 11-year-olds
Pfizer asked U.S. regulators Monday to expand use of its updated covid-19 booster shot to children ages 5 to 11.
Pfizer asked U.S. regulators Monday to expand use of its updated covid-19 booster shot to children ages 5 to 11.